Cyrus Biotechnology, Inc.
Seattle, Washington, United States · Biotechnology, Information Technology
Cyrus Biotechnology is a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, we are developing an early pipeline of innovative programs in multiple indications. We are also partnering with leading biotech and pharma companies and research institutes to bring collaborative programs forward from dis
Key facts
- Headquarters
- Seattle, Washington, United States
- Employees
- 26
- Industries
- Biotechnology, Information Technology
- Status
- Private
- Website
- cyrusbio.com
- Company page
Recent activity at Cyrus Biotechnology, Inc.
- : Cyrus Biotechnology
- : Cyrus Biotechnology
- : Cyrus Biotechnology
- : Cyrus Biotechnology presents its cutting-edge protein engineering capabilities and IgG protease candidate at the Hit ID Summit.
- : Cyrus Biotechnology, Inc.
- : Cyrus Biotechnology, Inc.
- : Cyrus Biotechnology, Inc.
- : Cyrus Biotechnology, Inc.
- : Cyrus Biotechnology, Inc.
Cyrus Biotechnology, Inc. funding history
| Date | Round | Amount |
|---|---|---|
| Jul 2025 | Seed | $1.1M |
| Dec 2024 | Seed | $15.9M |
| Jul 2021 | Venture | $9.1M |
| Sep 2020 | Seed | $1.1M |
| Jul 2017 | Venture | $8.0M |
Leadership
- Lucas, CEO and Co-Founder
- Erik Procko, Director
- Lucas Nivon, Executive Officer, Director, Promoter
- Yifan Song, Executive Officer, Director
- Chad Waite, Director
- Gus Tai, Director
- Eric Bell, Director
Verified email and direct lines for Cyrus Biotechnology, Inc.’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Cyrus Biotechnology, Inc. files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Cyrus Biotechnology, Inc. in the news
- Cyrus Biotechnology Spins out Levitate Bio, a Protein AI, Bioinformatics, and Rosetta Service Provider, to Bring Automated, Customized AI Solutions to Biopharma Drug Discovery - Business Wire (Jun 11, 2024)
- Cyrus Biotechnology Announces Selection of CYR212 as Clinical Candidate for Chronic IgG-driven Autoimmune Disease Including Myasthenia Gravis and Immune Thrombocytopenia - Business Wire (Jan 09, 2025)
- Cyrus Biotechnology Announces $18M Financing and Acquisition of Orthogonal Biologics to Form an Integrated Software-Driven Pre-Clinical-Stage Drug Discovery Firm - Business Wire (Dec 06, 2021)
- Cyrus Biotechnology Announces Potent in vivo Redosability of an Engineered IdeS Protease for IgG-driven Autoimmune Disease, Demonstrating No Anti-drug Antibodies - Business Wire (Dec 11, 2024)
- Cyrus Biotechnology to Present Its Novel IgG-degrading IdeS Enzyme Development Candidates for Autoimmune Indications at PepTalk Conference in San Diego - Business Wire (Jan 16, 2024)
Companies similar to Cyrus Biotechnology, Inc.
- MedRhythms · Biotechnology, Information Technology
- Outcomes4Me · Biotechnology, Information Technology
- Respiree · Biotechnology, Information Technology
- Aduro Clean Technologies · Biotechnology, Information Technology
- Ebenbuild · Biotechnology, Information Technology
About Cyrus Biotechnology, Inc.: questions and answers
What does Cyrus Biotechnology, Inc. do?
Cyrus Biotechnology is a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, we are developing an early pipeline of innovative programs in multiple indications. We are also partnering with leading biotech and pharma companies and research institutes to bring collaborative programs forward from dis
Where is Cyrus Biotechnology, Inc. headquartered?
Cyrus Biotechnology, Inc. is headquartered in Seattle, Washington, United States.
How many employees does Cyrus Biotechnology, Inc. have?
Cyrus Biotechnology, Inc. has about 26 employees.
Has Cyrus Biotechnology, Inc. raised funding?
Yes. Fundz has recorded 5 funding events for Cyrus Biotechnology, Inc.. The most recent, Seed of $1.1M, was in Jul 2025.
Who leads Cyrus Biotechnology, Inc.?
Lucas is a CEO and Co-Founder at Cyrus Biotechnology, Inc..
What is the latest news on Cyrus Biotechnology, Inc.?
On May 08, 2026, Cyrus Biotechnology
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy